{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:03:28Z","timestamp":1762866208367},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.gyobfe.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T09:30:53Z","timestamp":1371029453000},"page":"381-387","source":"Crossref","is-referenced-by-count":4,"title":["Diminuer la fr\u00e9quence des r\u00e8gles\u00a0: le point sur la contraception \u00e9tendue"],"prefix":"10.1016","volume":"41","author":[{"given":"P.","family":"This","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2013.05.003_bib0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(99)11159-0","article-title":"Nuisance or natural and healthy: should monthly menstruation be optional for women?","volume":"355","author":"Thomas","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2006.06.003","article-title":"Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0398-7620(05)84763-7","article-title":"Late fertility in Europe: some comparative and historical data","volume":"2","author":"Prioux","year":"2005","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2010.11.004","article-title":"The evolution of combined oral contraception: improving the risk-to-benefit ratio","volume":"84","author":"Burkman","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ogc.2007.01.001","article-title":"Extended cycle combined hormonal contraception","volume":"34","author":"Steinauer","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gyobfe.2004.12.004","article-title":"Pregnancies occurring during oral contraception: lessons from the GRECO study","volume":"34","author":"Barjot","year":"2006","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13625180400017776","article-title":"The Coraliance study: non-compliant behavior. Results after a 6-month follow-up of patients on oral contraceptives","volume":"9","author":"Aubeny","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.socscimed.2010.06.041","article-title":"\u201cMore natural but less normal\u201d: reconsidering medicalisation and agency through women's accounts of menstrual suppression","volume":"71","author":"Gunson","year":"2010","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(02)00474-2","article-title":"Amenorrhea associated with contraception-an international study on acceptability","volume":"67","author":"Glasier","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1297-9589(00)00023-0","article-title":"The experience of menstruation and its disorders in 603\u00a0women using contraception in 1999","volume":"28","author":"Mimoun","year":"2000","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.1988.tb120701.x","article-title":"Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill","volume":"149","author":"Rutter","year":"1988","journal-title":"Med J Aust"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bmj.320.7230.291","article-title":"Is norethisterone a lifestyle drug? Results of database analysis","volume":"320","author":"Shakespeare","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1745-7599.2004.tb00369.x","article-title":"The need to bleed: women's attitudes and beliefs about menstrual suppression","volume":"16","author":"Andrist","year":"2004","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.contraception.2011.02.004","article-title":"Extended-use oral contraceptives and medically induced amenorrhea: attitudes, knowledge and prescribing habits of physicians","volume":"84","author":"Frederick","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2004.06.008","article-title":"Women's and providers\u2019 attitudes toward menstrual suppression with extended use of oral contraceptives","volume":"70","author":"Andrist","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.contraception.2010.11.015","article-title":"Attitudes and prescribing patterns of extended-cycle oral contraceptives","volume":"84","author":"Seval","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1592\/phco.28.8.1033","article-title":"Extended- and continuous-cycle oral contraceptives","volume":"28","author":"Shrader","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/dei377","article-title":"Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials","volume":"21","author":"Edelman","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0115","first-page":"1","article-title":"Continuous or extended cycle vs cycle use of combined hormonal contraceptives fo contraception (Review)","volume":"8","author":"Edelman","year":"2010","journal-title":"Cochrane Library"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0010-7824(93)80141-H","article-title":"Long-interval treatment regimen with a desogestrel-containing oral contraceptive","volume":"48","author":"Cachrimanidou","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0010-7824(95)00101-F","article-title":"Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route","volume":"51","author":"Coutinho","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0029-7844(01)01555-1","article-title":"Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial","volume":"98","author":"Miller","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0029-7844(03)00014-0","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0165","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","article-title":"The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series","volume":"52","author":"Calhoun","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajog.2006.02.048","article-title":"Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen","volume":"195","author":"Sulak","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.contraception.2011.12.009","article-title":"Bleeding profile of a flexible extended regimen of ethinylestradiol\/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study","volume":"86","author":"Jensen","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0180","first-page":"552","article-title":"Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies","volume":"76","author":"Bracken","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2004.07.013","article-title":"Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen","volume":"71","author":"Anderson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2007.11.006","article-title":"Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo","volume":"77","author":"Anderson","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126days","volume":"73","author":"Foidart","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0205","series-title":"Contraception","first-page":"517","article-title":"Contraception du futur","author":"Serfaty","year":"2011"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.contraception.2009.07.011","article-title":"Effects of an oral contraceptive containing 30mcg ethinyl estradiol and 2mg dienogest on lipid metabolism during 1\u00a0year of conventional or extended-cycle use","volume":"81","author":"Wiegratz","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2011.07.009","article-title":"Effects of extended regimens of the contraceptive vaginal ring on carbohydrate metabolism","volume":"85","author":"Guazzelli","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.contraception.2011.08.014","article-title":"Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism","volume":"85","author":"Guazzelli","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0235","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(05)72800-2","article-title":"Reducing withdrawal bleeds","volume":"355","author":"Guillebaud","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2010.06.015","article-title":"Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen","volume":"83","author":"DiLiberti","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.contraception.2010.02.010","article-title":"Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate","volume":"82","author":"Guazzelli","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13625187.2012.726663","article-title":"Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt","volume":"17","author":"Laban","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0255","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0368-2315(06)76479-1","article-title":"Acceptability of intrauterine levonorgestrel delivery system (Mirena 52mg) after estrogen-progesterone oral contraception: results of a prospective multicentric study of 211\u00a0patients aged 25\u201335years","volume":"35","author":"Collinet","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0260","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/j.1600-0412.1999.780810.x","article-title":"Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12years of continuous use","volume":"78","author":"Ronnerdag","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0265","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.contraception.2006.12.016","article-title":"Long-term use of the levonorgestrel-releasing intrauterine system","volume":"75","author":"Inki","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0270","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0275","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(94)05017-9","article-title":"Long-acting injectable contraception with depot medroxyprogesterone acetate","volume":"170","author":"Kaunitz","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0280","first-page":"653","article-title":"A postmarketing observational study assessing acceptability and reliability of desogestrel only contrapceptive pill (Cerazette) in Indian women","volume":"104","author":"Ray","year":"2006","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0285","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jgyn.2008.06.013","article-title":"Update on the progestin-only contraception","volume":"37","author":"Madelenat","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.gyobfe.2013.05.003_bib0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.gyobfe.2009.11.018","article-title":"Shared medical decision making in gynaecology","volume":"38","author":"This","year":"2010","journal-title":"Gynecol Obstet Fertil"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913001306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958913001306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T08:03:20Z","timestamp":1595923400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958913001306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1297958913001306"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2013.05.003","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}